- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioage Labs Inc (BIOA)
"Bioage Labs Inc stock price live, this page displays NASDAQ BIOA stock exchange data. View the BIOA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioage Labs Inc real time stock price chart below.
What Is the Bioage Labs Inc Stock Price Today?
The Bioage Labs Inc stock price today is 3.90.
What Is the Stock Symbol for Bioage Labs Inc?
The stock symbol for Bioage Labs Inc is ""BIOA.""
What Stock Exchange Does Bioage Labs Inc Trade On?
Bioage Labs Inc is listed and trades on the NASDAQ stock exchange.
Is Bioage Labs Inc a Good Stock to Buy?
Determining whether Bioage Labs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOA quote. (ISIN: US09077V1008)"
What Is the Bioage Labs Inc Stock Price Today?
The Bioage Labs Inc stock price today is 3.90.
What Is the Stock Symbol for Bioage Labs Inc?
The stock symbol for Bioage Labs Inc is ""BIOA.""
What Stock Exchange Does Bioage Labs Inc Trade On?
Bioage Labs Inc is listed and trades on the NASDAQ stock exchange.
Is Bioage Labs Inc a Good Stock to Buy?
Determining whether Bioage Labs Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOA quote. (ISIN: US09077V1008)"
NASDAQ
Currency in USD
3.90
-0.21(-5.11%)
Closed·
After Hours
3.99+0.09(+2.31%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.90
4.12
52 wk Range
2.88
26.62
BIOA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BIOA is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.904.12
52 wk Range
2.8826.62
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIOA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
6.00
Upside
+53.85%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Bioage Labs Inc Company Profile
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
Bioage Labs Inc Earnings Call Summary for Q4/2024
- BioArctic reports Q4 2024 net revenues of $101M, with royalty revenues up 38% to SEK 96.7M
- Company projects profitability in 2025 with pre-tax profit of SEK 1B and milestone payments of $130M expected
- Stock declined 1.36% in aftermarket trading, down 76% over the past year, trading at $4.42
- R&D expenses expected to rise 50-80% in 2025; company exploring new indications and expanding infusion capacity
- CEO Gunilla Oswald announces "BioArctic two point zero" era, emphasizing profitability and future growth
Last Updated: 2025/02/13, 11:38
Read Full TranscriptCompare BIOA to Peers and Sector
Metrics to compare | BIOA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.0x | −0.1x | −0.5x | |
PEG Ratio | −0.02 | 0.00 | 0.00 | |
Price/Book | 0.4x | 0.0x | 2.6x | |
Price / LTM Sales | 96.4x | 0.7x | 3.0x | |
Upside (Analyst Target) | 28.2% | 160.7% | 48.7% | |
Fair Value Upside | Unlock | 20.0% | 9.2% | Unlock |
Analyst Ratings
0 Buy
3 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 6.00
(+53.85% Upside)
Earnings
Latest Release
May 06, 2025
EPS / Forecast
-0.36 / --
Revenue / Forecast
1.45M / --
FAQ
What Is the Bioage Labs (BIOA) Stock Price Today?
The Bioage Labs stock price today is 3.90
What Stock Exchange Does Bioage Labs Trade On?
Bioage Labs is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Bioage Labs?
The stock symbol for Bioage Labs is "BIOA."
What Is the Bioage Labs Market Cap?
As of today, Bioage Labs market cap is 139.82M.
What Is Bioage Labs's Earnings Per Share (TTM)?
The Bioage Labs EPS (TTM) is -3.69.
From a Technical Analysis Perspective, Is BIOA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Bioage Labs Stock Split?
Bioage Labs has split 0 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.